AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)
CUSIP: 03152W109
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 316,644,581
- Total 13F shares
- 320,934,226
- Share change
- +3,271,691
- Total reported value
- $4,568,022,027
- Put/Call ratio
- 186%
- Price per share
- $14.24
- Number of holders
- 331
- Value change
- +$318,753,963
- Number of buys
- 195
- Number of sells
- 130
Quarterly Holders Quick Answers
What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03152W109:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9.3%
|
29,534,029
|
$232,728,149 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
|
Company |
0.4%
from 13D/G
|
28,628,829
|
$225,595,173 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.4%
from 13D/G
|
25,848,965
|
$203,689,844 | — | 30 Sep 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13D/G
13F
|
Company |
3.4%
|
10,627,717
|
$151,763,799 | -$76,348,548 | 31 Dec 2025 | |
| Avoro Capital Advisors LLC |
13D/G
13F
|
Company |
4.9%
|
15,025,000
|
$118,397,000 | -$43,143,000 | 30 Sep 2025 | |
| Redmile Group, LLC |
13D/G
13F
|
Company |
4.6%
|
14,184,495
|
$106,667,402 | $0 | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.7%
|
11,809,796
|
$93,061,192 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
11,562,939
|
$91,115,959 | — | 30 Sep 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
3.1%
|
9,750,000
|
$76,830,000 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.6%
|
8,250,140
|
$65,011,103 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.3%
|
7,156,557
|
$56,393,679 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.2%
|
7,109,070
|
$56,019,468 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
7,099,093
|
$55,950,545 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.1%
|
6,788,164
|
$53,619,642 | — | 30 Sep 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
|
Company |
2.4%
from 13D/G
|
6,370,851
|
$50,202,306 | — | 30 Sep 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
1.7%
|
5,367,798
|
$42,298,248 | — | 30 Sep 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.5%
|
4,690,000
|
$36,957,200 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.5%
|
4,622,397
|
$36,424,489 | — | 30 Sep 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.4%
|
4,560,810
|
$35,939,000 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.2%
|
3,868,210
|
$30,481,495 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
3,784,218
|
$29,819,639 | — | 30 Sep 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.2%
|
3,708,738
|
$29,224,855 | — | 30 Sep 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
1.1%
|
3,434,717
|
$27,065,570 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
3,337,375
|
$26,298,515 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
3,198,670
|
$25,205,520 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.87%
|
2,752,098
|
$21,686,532 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.78%
|
2,480,598
|
$19,547,112 | — | 30 Sep 2025 | |
| Blackstone Inc. |
13F
|
Company |
0.78%
|
2,467,104
|
$19,440,780 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.78%
|
2,466,021
|
$19,431,657 | — | 30 Sep 2025 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.67%
|
2,118,696
|
$16,695,324 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.67%
|
2,116,166
|
$16,675,388 | — | 30 Sep 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.66%
|
2,075,000
|
$16,351,000 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.64%
|
2,019,556
|
$15,914,101 | — | 30 Sep 2025 | |
| Iron Triangle Partners LP |
13F
|
Company |
0.62%
|
1,971,260
|
$15,533,529 | — | 30 Sep 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.62%
|
1,947,374
|
$15,345,307 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.61%
|
1,943,171
|
$15,312,187 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.58%
|
1,848,454
|
$14,565,818 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.57%
|
1,817,010
|
$14,318,039 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.55%
|
1,749,579
|
$13,786,683 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.55%
|
1,730,855
|
$13,639,137 | — | 30 Sep 2025 | |
| Prosight Management, LP |
13F
|
Company |
0.54%
|
1,709,533
|
$13,471,120 | — | 30 Sep 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.53%
|
1,687,318
|
$13,296,066 | — | 30 Sep 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.52%
|
1,645,400
|
$12,965,752 | — | 30 Sep 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.46%
|
1,448,678
|
$11,415,583 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.43%
|
1,377,064
|
$10,851,264 | — | 30 Sep 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.43%
|
1,364,065
|
$10,748,829 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.41%
|
1,313,373
|
$10,349,379 | — | 30 Sep 2025 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
0.4%
|
1,260,634
|
$9,933,796 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.35%
|
1,110,382
|
$8,749,810 | — | 30 Sep 2025 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.34%
|
1,084,278
|
$8,544,111 | — | 30 Sep 2025 |
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q4 2025
As of 31 Dec 2025,
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) was held by
331 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
320,934,226 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, HBK INVESTMENTS L P, STATE STREET CORP, Pentwater Capital Management LP, Bellevue Group AG, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, PERCEPTIVE ADVISORS LLC, and GOLDMAN SACHS GROUP INC.
This page lists
331
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
284
Q4 2025 holders
331
Holder diff
47
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.